209 related articles for article (PubMed ID: 17240442)
1. Pharmacologically active microcarriers releasing glial cell line - derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats.
Tatard VM; Sindji L; Branton JG; Aubert-Pouëssel A; Colleau J; Benoit JP; Montero-Menei CN
Biomaterials; 2007 Apr; 28(11):1978-88. PubMed ID: 17240442
[TBL] [Abstract][Full Text] [Related]
2. Effect of GDNF-releasing biodegradable microspheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts.
Clavreul A; Sindji L; Aubert-Pouëssel A; Benoît JP; Menei P; Montero-Menei CN
Eur J Pharm Biopharm; 2006 Jun; 63(2):221-8. PubMed ID: 16497494
[TBL] [Abstract][Full Text] [Related]
3. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
4. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
[TBL] [Abstract][Full Text] [Related]
5. Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.
Garbayo E; Montero-Menei CN; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
J Control Release; 2009 Apr; 135(2):119-26. PubMed ID: 19154763
[TBL] [Abstract][Full Text] [Related]
6. Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line.
Meyer M; Johansen J; Gramsbergen JB; Johansen TE; Zimmer J
Exp Neurol; 2000 Jul; 164(1):82-93. PubMed ID: 10877918
[TBL] [Abstract][Full Text] [Related]
7. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
McLeod M; Hong M; Mukhida K; Sadi D; Ulalia R; Mendez I
Eur J Neurosci; 2006 Jul; 24(2):361-70. PubMed ID: 16903847
[TBL] [Abstract][Full Text] [Related]
9. Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.
Ahn YH; Bensadoun JC; Aebischer P; Zurn AD; Seiger A; Björklund A; Lindvall O; Wahlberg L; Brundin P; Kaminski Schierle GS
Brain Res Bull; 2005 Jul; 66(2):135-42. PubMed ID: 15982530
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain.
Wood TK; McDermott KW; Sullivan AM
J Neurosci Res; 2005 Jun; 80(6):759-66. PubMed ID: 15880784
[TBL] [Abstract][Full Text] [Related]
11. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates.
Behrstock S; Ebert A; McHugh J; Vosberg S; Moore J; Schneider B; Capowski E; Hei D; Kordower J; Aebischer P; Svendsen CN
Gene Ther; 2006 Mar; 13(5):379-88. PubMed ID: 16355116
[TBL] [Abstract][Full Text] [Related]
12. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.
Ebert AD; Beres AJ; Barber AE; Svendsen CN
Exp Neurol; 2008 Jan; 209(1):213-23. PubMed ID: 18061591
[TBL] [Abstract][Full Text] [Related]
13. Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats.
Date I; Shingo T; Yoshida H; Fujiwara K; Kobayashi K; Takeuchi A; Ohmoto T
Cell Transplant; 2001; 10(4-5):397-401. PubMed ID: 11549061
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats.
Delcroix GJ; Garbayo E; Sindji L; Thomas O; Vanpouille-Box C; Schiller PC; Montero-Menei CN
Biomaterials; 2011 Feb; 32(6):1560-73. PubMed ID: 21074844
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.
Shingo T; Date I; Yoshida H; Ohmoto T
J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of glial cell line-derived neurotrophic factor on A9 and A10 dopamine neuron survival in vitro.
Borgal L; Hong M; Sadi D; Mendez I
Neuroscience; 2007 Jul; 147(3):712-9. PubMed ID: 17583436
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease.
Jollivet C; Aubert-Pouessel A; Clavreul A; Venier-Julienne MC; Montero-Menei CN; Benoit JP; Menei P
Neurosci Lett; 2004 Feb; 356(3):207-10. PubMed ID: 15036631
[TBL] [Abstract][Full Text] [Related]
18. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
[TBL] [Abstract][Full Text] [Related]
19. Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
Do Thi NA; Saillour P; Ferrero L; Paunio T; Mallet J
Gene Ther; 2007 Mar; 14(5):441-50. PubMed ID: 17093508
[TBL] [Abstract][Full Text] [Related]
20. Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.
Kupsch A; Oertel WH; Earl CD; Sautter J
J Neural Transm Suppl; 1995; 46():193-207. PubMed ID: 8821056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]